Clinical Trial Update: ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of ChronoFOLFOX plus Avastin in metastatic colorectal cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• ChronoFOLFOX

Snippet

Sponsor: Southwestern Regional Medical Center | Conditions: Colorectal Neoplasms | Phase 2 | Status: TERMINATED